These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21444357)

  • 21. The Activity of Chemotherapy in Inflammatory Myofibroblastic Tumors: A Multicenter, European Retrospective Case Series Analysis.
    Baldi GG; Brahmi M; Lo Vullo S; Cojocaru E; Mir O; Casanova M; Vincenzi B; De Pas TM; Grignani G; Pantaleo MA; Blay JY; Jones RL; Le Cesne A; Frezza AM; Gronchi A; Collini P; Dei Tos AP; Morosi C; Mariani L; Casali PG; Stacchiotti S
    Oncologist; 2020 Nov; 25(11):e1777-e1784. PubMed ID: 32584482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effective treatment of multifocal aggressive fibromatosis with low-dose chemotherapy.
    Caglar K; Ozyönüm H; Akalin M; Balci S
    Turk J Pediatr; 2006; 48(4):365-8. PubMed ID: 17290575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
    Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
    Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real-world outcomes of patients with locally advanced or metastatic epithelioid sarcoma.
    Gounder MM; Merriam P; Ratan R; Patel SR; Chugh R; Villalobos VM; Thornton M; Van Tine BA; Abdelhamid AH; Whalen J; Yang J; Rajarethinam A; Duh MS; Bobbili PJ; Huynh L; Totev TI; Lax AK; Agarwal S; Demetri GD
    Cancer; 2021 Apr; 127(8):1311-1317. PubMed ID: 33296083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imatinib induces sustained progression arrest in RECIST progressive desmoid tumours: Final results of a phase II study of the German Interdisciplinary Sarcoma Group (GISG).
    Kasper B; Gruenwald V; Reichardt P; Bauer S; Rauch G; Limprecht R; Sommer M; Dimitrakopoulou-Strauss A; Pilz L; Haller F; Hohenberger P
    Eur J Cancer; 2017 May; 76():60-67. PubMed ID: 28282612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aggressive fibromatosis in children and adolescents: the Italian experience.
    Meazza C; Bisogno G; Gronchi A; Fiore M; Cecchetto G; Alaggio R; Milano GM; Casanova M; Carli M; Ferrari A
    Cancer; 2010 Jan; 116(1):233-40. PubMed ID: 19950127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pazopanib therapy for desmoid tumors in adolescent and young adult patients.
    Agresta L; Kim H; Turpin BK; Nagarajan R; Plemmons A; Szabo S; Dasgupta R; Sorger JI; Pressey JG
    Pediatr Blood Cancer; 2018 Jun; 65(6):e26968. PubMed ID: 29384266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Favorable clinical efficacy of cytotoxic chemotherapy in patients with progressive desmoid tumors: a retrospective real-world study.
    Oh CR; Jeong H; Kim W; Lee JS; Song SY; Song JS; Cho KJ; Chung HW; Lee MH; Hong JY; Lee J; Kim JE; Ahn JH
    Int J Clin Oncol; 2024 Jun; 29(6):853-861. PubMed ID: 38526622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-dose chemotherapy with vinblastine and methotrexate in childhood desmoid tumors.
    Reich S; Overberg-Schmidt US; Bührer C; Henze G
    J Clin Oncol; 1999 Mar; 17(3):1086. PubMed ID: 10071306
    [No Abstract]   [Full Text] [Related]  

  • 30. Multimodal treatment of children with unresectable or recurrent desmoid tumors: an 11-year longitudinal observational study.
    Lackner H; Urban C; Benesch M; Raith J; Moser A; Sovinz P; Schwinger W; Dornbusch HJ; Triebl-Roth K
    J Pediatr Hematol Oncol; 2004 Aug; 26(8):518-22. PubMed ID: 15284591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnetic resonance imaging patterns of tumor response to chemotherapy in desmoid-type fibromatosis.
    Zanchetta E; Ciniselli CM; Bardelli A; Colombo C; Stacchiotti S; Baldi GG; Provenzano S; Bertulli R; Bini F; Casale A; Greco FG; Ferrari A; Verderio P; Fiore M; Gronchi A; Casali PG; Morosi C; Palassini E
    Cancer Med; 2021 Jul; 10(13):4356-4365. PubMed ID: 34102009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response to chemotherapy of solitary fibrous tumour: a retrospective study.
    Stacchiotti S; Libertini M; Negri T; Palassini E; Gronchi A; Fatigoni S; Poletti P; Vincenzi B; Dei Tos AP; Mariani L; Pilotti S; Casali PG
    Eur J Cancer; 2013 Jul; 49(10):2376-83. PubMed ID: 23566418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progressive Desmoid Tumor: Radiomics Compared With Conventional Response Criteria for Predicting Progression During Systemic Therapy-A Multicenter Study by the French Sarcoma Group.
    Crombé A; Kind M; Ray-Coquard I; Isambert N; Chevreau C; André T; Lebbe C; Cesne AL; Bompas E; Piperno-Neumann S; Saada E; Bouhamama A; Blay JY; Italiano A;
    AJR Am J Roentgenol; 2020 Dec; 215(6):1539-1548. PubMed ID: 32991215
    [No Abstract]   [Full Text] [Related]  

  • 34. Successful low-dose chemotherapy using vinblastine and methotrexate for the treatment of an ileoanal pouch mesenteric desmoid tumor: report of a case.
    Kono T; Tomita I; Chisato N; Matsuda M; Kakisaka A; Kasai S
    Dis Colon Rectum; 2004 Feb; 47(2):246-9. PubMed ID: 15043298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vinorelbine and cisplatin for metastatic breast cancer: a salvage regimen in patients progressing after docetaxel and anthracycline treatment.
    Vassilomanolakis M; Koumakis G; Demiri M; Missitzis J; Barbounis V; Efremidis AP
    Cancer Invest; 2003; 21(4):497-504. PubMed ID: 14533438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PROMIS Function Scores Are Lower in Patients Who Underwent More Aggressive Local Treatment for Desmoid Tumors.
    Newman ET; Lans J; Kim J; Ferrone M; Ready J; Schwab J; Raskin K; Calderon SL
    Clin Orthop Relat Res; 2020 Mar; 478(3):563-577. PubMed ID: 31429829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sorafenib for Advanced and Refractory Desmoid Tumors.
    Gounder MM; Mahoney MR; Van Tine BA; Ravi V; Attia S; Deshpande HA; Gupta AA; Milhem MM; Conry RM; Movva S; Pishvaian MJ; Riedel RF; Sabagh T; Tap WD; Horvat N; Basch E; Schwartz LH; Maki RG; Agaram NP; Lefkowitz RA; Mazaheri Y; Yamashita R; Wright JJ; Dueck AC; Schwartz GK
    N Engl J Med; 2018 Dec; 379(25):2417-2428. PubMed ID: 30575484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hormonal manipulation with toremifene in sporadic desmoid-type fibromatosis.
    Fiore M; Colombo C; Radaelli S; Callegaro D; Palassini E; Barisella M; Morosi C; Baldi GG; Stacchiotti S; Casali PG; Gronchi A
    Eur J Cancer; 2015 Dec; 51(18):2800-7. PubMed ID: 26602014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vinorelbine and cisplatin in metastatic breast cancer patients previously treated with anthracyclines.
    Vassilomanolakis M; Koumakis G; Barbounis V; Demiri M; Pateras H; Efremidis AP
    Ann Oncol; 2000 Sep; 11(9):1155-60. PubMed ID: 11061611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pirarubicin versus doxorubicin in neoadjuvant/adjuvant chemotherapy for stage IIB limb high-grade osteosarcoma: does the analog matter?
    Yu W; Tang L; Lin F; Yao Y; Shen Z
    Med Oncol; 2015 Jan; 32(1):307. PubMed ID: 25432694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.